Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden
文献类型:期刊论文
作者 | Hong, Xiaohua2; Shen, Aijun1![]() |
刊名 | CANCER RESEARCH
![]() |
出版日期 | 2019-07-01 |
卷号 | 79期号:13页码:2 |
ISSN号 | 0008-5472 |
DOI | 10.1158/1538-7445.AM2019-4011 |
WOS研究方向 | Oncology |
语种 | 英语 |
WOS记录号 | WOS:000488279403408 |
出版者 | AMER ASSOC CANCER RESEARCH |
源URL | [http://119.78.100.183/handle/2S10ELR8/282682] ![]() |
专题 | 新药研究国家重点实验室 |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai, Peoples R China 2.Huazhong Univ Sci & Technol, Coll Med, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China 3.3D Med Inc, Dept Med, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Hong, Xiaohua,Shen, Aijun,Xu, Yu,et al. Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden[J]. CANCER RESEARCH,2019,79(13):2. |
APA | Hong, Xiaohua.,Shen, Aijun.,Xu, Yu.,Li, Chengcheng.,Wang, Guoqiang.,...&Qi, Chuang.(2019).Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden.CANCER RESEARCH,79(13),2. |
MLA | Hong, Xiaohua,et al."Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden".CANCER RESEARCH 79.13(2019):2. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。